Frequency Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Public

  • Employees
  • 48

Employees

  • Investments
  • 1

  • Share Price
  • $14.98
  • (As of Friday Closing)

Frequency Therapeutics General Information

Description

Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 75 Hayden Avenue
  • Suite 300
  • Lexington, MA 02421
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Frequency Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$14.98 $14.14 $9.15 - $279.50 $11.1M 739K 3.42K -$83.00

Frequency Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV (5,005) 80,651 75,423 967,494
Revenue 0 0 14,068 36,984
EBITDA (57,912) (79,182) (81,529) (26,324)
Net Income (59,315) (81,580) (84,686) (26,511)
Total Assets 46,349 121,238 185,358 264,722
Total Debt 1,427 42,949 45,598 45,994
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Frequency Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Frequency Therapeutics‘s full profile, request access.

Request a free trial

Frequency Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Frequency Therapeutics‘s full profile, request access.

Request a free trial

Frequency Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to
Drug Discovery
Lexington, MA
48 As of 2022
00000
000000&0 00000

000000

consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolo
0000 000000000
Boston, MA
00 As of 0000
00000
0000 0000-00-00
000000&0 00000

000000

d minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
0000 000000000
San Diego, CA
00 As of 0000
00000
0000 0000-00-00
0000000000 0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Frequency Therapeutics Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Decibel Therapeutics Formerly VC-backed Boston, MA 00 00000 000000&0 00000
Continuem Therapeutics Venture Capital-Backed San Diego, CA 00 00000 0000000000 0 00000
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
Neurona Therapeutics Venture Capital-Backed South San Francisco, CA 00 00000 00000000000 00000
Oligomerix Venture Capital-Backed White Plains, NY 00 00.000 0000000000 00.000
You’re viewing 5 of 25 competitors. Get the full list »

Frequency Therapeutics Executive Team (14)

Name Title Board Seat Contact Info
David Lucchino Board Member, President, Chief Executive Officer & Co-Founder
Quentin McCubbin Ph.D Chief Manufacturing Officer
You’re viewing 2 of 14 executive team members. Get the full list »

Frequency Therapeutics Board Members (10)

Name Representing Role Since
Cynthia Feldmann Self Board Member 000 0000
Joel Marcus JD Self Board Member 000 0000
Michael Huang Taiwania Capital Board Member 000 0000
Robert Langer Ph.D Frequency Therapeutics Board Member 000 0000
Timothy Barberich Self Board Member & Vice Chairman 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Frequency Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Frequency Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Korro Bio 03-Nov-2023 0000000 00 Drug Discovery 00000 000
To view Frequency Therapeutics’s complete acquisitions history, request access »

Frequency Therapeutics ESG

Risk Overview

Risk Rating

Updated April, 01, 2022

33.72 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,638

Rank

00.0

Percentile

Pharmaceuticals

Industry

00 of 1,008

Rank

00.00

Percentile

Biotechnology

Subindustry

00 of 465

Rank

00.00

Percentile

To view Frequency Therapeutics’s complete esg history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »